Data_Sheet_1_Determination of Causative Human Papillomavirus Type in Tissue Specimens of Common Warts Based on Estimated Viral Loads.xlsx
Background: Assessment of human papillomavirus (HPV) type-specific viral load (VL) is a valid tool for determining the etiology of HPV-related skin tumors, especially when more than one HPV type is detected within one lesion.
Methods: The causative HPV type was determined in 185 fresh-frozen tissue specimens of histologically confirmed common warts (CWs) collected from 121 immunocompetent patients. All tissues were tested using the type-specific quantitative real-time polymerase chain reactions (PCR) for the most common wart-associated Alpha-PV (HPV2/27/57) and Mu-PV types (HPV1/63/204). The presence of 23 additional low-risk HPVs was evaluated using a conventional wide-spectrum PCR.
Results: HPV DNA was detected in 176/185 (95.1%) CWs and multiple HPV types in 71/185 (38.4%) lesions. Using the VL approach and a robust cutoff of one viral copy/cell established in this study, HPV2/27/57 were determined as causative agents in 41/53 (77.3%) and 53/71 (74.7%) CWs with single and multiple HPVs, respectively.
Conclusions: CWs are mostly etiologically associated with HPV2/27/57 and only rarely with HPV1. In the majority of CWs containing multiple HPVs, a single HPV type was present in high concentration, indicating etiological association. No significant differences in VLs of lesion-causing HPV types in CWs containing single or multiple HPVs were found.
History
References
- https://doi.org//10.1002/jmv.23519
- https://doi.org//10.1111/j.1524-4725.2012.02558.x
- https://doi.org//10.1111/j.1365-2133.2008.08937.x
- https://doi.org//10.1016/j.virol.2010.02.002
- https://doi.org//10.1038/sj.jid.5700776
- https://doi.org//10.1016/j.jcv.2012.07.014
- https://doi.org//10.1016/j.jcv.2013.02.021
- https://doi.org//10.1007/BF00376818
- https://doi.org//10.1056/NEJMicm055674
- https://doi.org//10.1016/j.jcv.2011.06.016
- https://doi.org//10.1111/bjd.13216
- https://doi.org//10.1111/j.1365-2133.1994.tb02894.x
- https://doi.org//10.1006/viro.1993.1320
- https://doi.org//10.3390/v7072802
- https://doi.org//10.1016/j.jdermsci.2014.11.002
- https://doi.org//10.1111/1523-1747.ep12506324
- https://doi.org//10.1128/JCM.37.11.3545-3555.1999
- https://doi.org//10.1111/bjd.15758
- https://doi.org//10.15570/actaapa.2016.20
- https://doi.org//10.1371/journal.pone.0169533
- https://doi.org//10.1158/1055-9965.EPI-07-2922
- https://doi.org//10.1016/0738-081X(85)90051-3
- https://doi.org//10.1016/j.virol.2009.05.006
- https://doi.org//10.15570/actaapa.2015.7
- https://doi.org//10.1111/j.1365-2133.2009.09297.x
- https://doi.org//10.1016/S0895-3988(09)60023-4
- https://doi.org//10.1111/jcmm.12211
- https://doi.org//10.1002/path.3970
- https://doi.org//10.1111/j.1365-2133.1993.tb00169.x
- https://doi.org//10.1128/JCM.00634-11
- https://doi.org//10.1128/JVI.01582-09
- https://doi.org//10.1016/j.vaccine.2009.11.048
- https://doi.org//10.1097/MD.0000000000004332
- https://doi.org//10.1371/journal.pone.0175892
- https://doi.org//10.1111/j.1365-2133.2009.09564.x
- https://doi.org//10.1111/jdv.13548
- https://doi.org//10.1111/j.1365-2133.2009.09160.x
- https://doi.org//10.1371/journal.ppat.1003924
- https://doi.org//10.1001/archderm.143.10.1267
CC BY 4.0